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Abstract: Background and Objectives: Carpal tunnel syndrome (CTS) is defined as the impaction of the median nerve in 
the carpal tunnel of the wrist. Metabolic disorders are closely associated with CTS; and metabolic syndrome (MS) is 
found to be more in patients with CTS. Metabolic syndrome is highly prevalent in patients with type 2 diabetes. This 
study was conducted to determine the prevalence of CTS in diabetic patients with and without metabolic syndrome. 
Material and Methods: In this cross-sectional study, 439 diabetic patients that participated in the study of risk factors for 
coronary artery disease in Kerman (KERCADRS) were enrolled. People with positive clinical symptoms for CTS and a 
positive Boston questionnaire, were referred to a neurologist for further diagnosis. For the diagnosis of metabolic 
syndrome, three criteria (ATPIII, IDF and new criteria in Kerman) were used. Also, electro-diagnostic tests were used for 
the diagnosis of CTS. Data were analyzed by independent t-test and chi square test in SPSS20. 
Results: The prevalence of CTS in diabetic patients was 24.23%. The prevalence of the disorder in male and female 
patients was 16.21% and 30.65%, respectively. The results showed that there is no significant difference in the 
prevalence of CTS in diabetic people with and without metabolic syndrome, in overall as well as sex subgroups. 
Discussion and Conclusion: The higher prevalence of CTS in diabetic patients in this study compared to other studies 
shows the lack of prevention and case finding in diabetic patients. Therefore, screening, educating and informing at risk 
people about the disease is necessary. 
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INTRODUCTION 
Carpal Tunnel Syndrome (CTS) is defined as the 
impaction of the median nerve in the carpal tunnel of 
the wrist and is the most common entrapment that 
affects upper limbs. The onset of the disease usually 
starts by tingling and numbness or pain in the median 
nerve area and eventually leads to weakness and 
impaired hand function [1]. The signs usually appear 
gradually [2]. 
The prevalence of CTS varies in different countries 
[3]. The disease usually occurs in 30-60 years old and 
is more prevalent in females. The female to male ratio 
for prevalence of the disease varies from 3.1 to 10.1. 
Studies show that 14.4% of people have clinical 
symptoms of CTS and 2.7% of the general population 
is affected by this syndrome in terms of clinical and 
electro-diagnostic tests. The prevalence of this 
syndrome in diabetic patients varies from 14% in 
patients without neuropathy to 30% in patients with 
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neuropathy. Currently, there is no precise information 
regarding the prevalence of this syndrome in Iran  
[1, 4].  
In order to diagnosis the disease, clinical history 
and physical examination, two-point discrimination test, 
Weinstein test and other preclinical tests are used, but, 
the best method for diagnosis, determining severity, 
and ruling out other causes with similar symptoms is 
the electro-diagnostic tests [5]. Currently, electro-
diagnostic tests are considered as the gold standard for 
the diagnosis of suspected cases of carpal tunnel 
syndrome [6]. 
So far, researchers have identified several factors 
that may cause or contribute to the development of 
CTS. These factors include working conditions, such as 
the frequent use of hand; and health conditions 
including non-inflammatory synovial fibrosis, diabetes, 
metabolic syndrome, pregnancy, menopause and 
rheumatoid arthritis as well as personal factors such as 
obesity, female sex, heredity, age, smoking and 
alcohol. But already, the general agreement is that the 
main cause of CTS is unknown [5]. 
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Metabolic disorders are closely associated with 
CTS. Metabolic syndrome is characterized by 
abdominal obesity, high blood pressure, elevated blood 
sugar and blood fats and is often associated with the 
presence of carpal tunnel syndrome. The incidence of 
metabolic syndrome is more in patients with CTS, and 
CTS in patients with metabolic syndrome is more 
severe [2, 7]. 
Different definitions of metabolic syndrome have 
been proposed and are currently used [8]. There are no 
single accepted criteria for the diagnosis of the 
syndrome. Currently, most studies use the Adult 
Treatment Panel criteria (ATPIII) to identify subjects 
with metabolic syndrome [9]. The International 
Diabetes Federation (IDF) presented a definition for 
diagnosing people with metabolic syndrome that is 
applicable for different ethnic populations [10].  
The metabolic syndrome is highly prevalent in 
patients with type 2 diabetes [11]. In Iran, the 
prevalence of this syndrome in diabetic patients 
according to ATPIII and IDF criteria were 73.1% and 
69.4%, respectively [12]. According to a study in UK, 
the prevalence of the syndrome among diabetics was 
91.70% and 87.60% in males and 94.80% and 94.20% 
in females based on ATPIII and IDF criteria 
respectively [13].  
As diabetic patients and people with metabolic 
syndrome are at risk for CTS, this study aimed to 
determine the prevalence of the disease in diabetic 
patients with and without metabolic syndrome and by 
different diagnostic criteria. 
MATERIAL AND METHODS 
In this cross-sectional study, 439 diabetic patients 
that participated in the study of risk factors for coronary 
artery disease in Kerman were enrolled. In this study 
data was gathered in Kerman city and its suburbsin 
2013. We called diabetic patients (439) from the 
Physiology Research Center in Kerman and those with 
positive symptoms of carpal tunnel syndrome (including 
numbness, burning, tingling in the fingers and palm of 
the hand, wrist pain, hand and forearm pain, decreased 
grip strength, weakness in the thumb, and positive 
Boston's questionnaire) (138) were referred to a 
neurologist for further diagnosis in the Neurology 
Research Center in Kerman. In this study, any 
neurological disease which could affect the median 
nerve, such as uremic neuropathy or any fracture 
which can lead to deformity or denervation, as well as 
patients with obvious neuropathy or a diagnosis of this 
disease during electro-diagnostic tests, were excluded. 
Demographic and basic metabolic information (BMI, 
systolic blood pressure, diastolic blood pressure, 
cardiovascular disease, fasting blood sugar, 
cholesterol, HDL, LDL) as well as information related to 
the diagnosis of metabolic syndrome, was obtained 
from the study of risk factors for coronary artery 
disease in Kerman [14]. Measurement of the median 
nerve indications (median nervemotor distal latency, 
median nerve motor amplitude, median nervemotor 
conduction velocity, median nerve sensory onset 
latency, median nerve sensory amplitude, median 
nerve sensory conduction velocity) and wrist 
dimensions was measured by a neurologist. 
For the diagnosis of metabolic syndrome, the three 
criteria ATPIII [15], IDF [16] and new criteria  in Kerman 
[17] were used (Table 1).  
To diagnose CTS, an electro-diagnostic test using 
EMG neon made in Japan was used. This test was 
performed at 32-34°C on skin surface and at room 
temperature. The test was conducted as following: The 
receiving location of median nerve’s motor potential 
was the Abductor Pollicis Brevis muscle and the 
stimulation location of the median nerve was located in 
the wrist and with 6.5 cm distance from the location of 
the receiving stimulation. The position for assessing the 
sensory stimulation of median nerve was the wrist 
horizontal creases, and the receiving location for the 
sensory potential was the proximal of the index finger, 
located at 13 cm of the stimulation receiving place. 
Table 2 shows the classification of disease severity. 
Inclusion criteria to study included: diabetic patients 
with positive symptoms of carpal tunnel syndrome and 
exclusion criteria was a neurological disease that 
affects the median nerve, included Uremic neuropathy 
or nerve injury leading to deformity or denervation, as 
well as patients who had obvious neuropathy. 
Also the dimensions of the wrist were measured by 
using a calipers with 1mm measurement accuracy. 
Anterior-posterior size and the median lateral size of 
the wrist are defined as AP and ML, respectively. We 
can obtain the dimension of the wrist by dividing AP to 
ML and its normal measure is considered as 0.7 and 
less.  
Data were analyzed by independent t-test and chi 
square test in SPSS20.  
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RESULTS 
Among 439 Patients with type 2 diabetes, 224 
subjects (55.6%) were female and 196 subjects 
(44.4%) were male. The mean age of the participants 
was 56.12±11.25 (54.70±10.41 for females and 
57.70±12.06 for males). Among the participants, 138 
subjects had clinical signs of CTS, but only 105 
subjects visited the neurologist. Based on 
electrophysiological findings, 81 subjects had CTS. 
Table 3 shows the demographic and initial metabolic 
information in patients with and without clinical signs. 
There was a significant difference between sex and 
systolic blood pressure in patients with and without 
clinical signs of CTS, but there is no significant 
difference in other variables in these patients. Also a 
significant difference was observed in the age and 
dimension of right hand wrist variables in true patients 
(patients with positive electro-diagnostic tests) and 
healthy people (based on electro-diagnosis tests), but 
there was no significant differences in other variables 
(Table 4).  
The prevalence of CTS in diabetic patients was 
24.23%. The prevalence of the disorder in male and 
female patients was 16.21% and 30.65%, respectively.  
The prevalence of the disease in patients with and 
without metabolic syndrome was estimated based on 
the 3 diagnostic criteria for all subjects and sex 
subgroups. The results showed that there is no 
significant difference in the prevalence of carpal tunnel 
syndrome in people with and without metabolic 
syndrome, according to the 3 criteria as well as sex 
subgroups (Table 5).  
Table 6 shows the prevalence of CTS according to 
different criteria. In all groups the prevalence of carpal 
tunnel syndrome in patients with metabolic syndrome 
was more than patients without metabolic syndrome, 
but these differences were not significant in any group.  
The frequency of carpal tunnel syndrome based on 
disease severity, left and right hand, and the 3 different 
diagnostic criteria of metabolic syndrome, was 
calculated. There was no significant difference in 
disease severity in patients with and without metabolic 
syndrome based on the 3 criteria in each hand.  
DISCUSSION 
In this study, the prevalence of carpal tunnel 
syndrome in diabetic patients was 24.23%. According 
to a study by Perkins et al. in Toronto General Hospital 
Table 1: Diagnosis of Metabolic Syndrome as Per Different Criteria 
ATPIII IDF NEW 
Presence of ≥3 of the following: 
(i) Waist circumference 
(>90 cm in men, >80 cm in 
women) 
(ii) SBP ≥130 mmHg and/or 
DBP ≥85 mmHg or medical 
treatment of previously 
diagnosed hypertension 
(iii) TG≥150 mg/dl 
(iv) HDL-C <40 mg/dl in 
men, <50 mg/dl in women 
(v) Fasting glucose >110 
mg/d 
Presence of central obesity with waist 
circumference >90 cm (men) and >80 cm 
(women) plus any 2 of the following: 
(i) TG >150 mg/dl or specific treatment for this 
lipid abnormality 
(ii) HDL-C <40 mg/dl (men), <50 mg/dl 
(women) or specific treatment for this lipid 
abnormality 
(iii) SBP >130 mmHg and/or DBP >85 
mmHg or medical treatment for previously 
diagnosed hypertension 
(iv) Fasting plasma glucose (>100 mg/dl) or 
previously diagnosed type 2 diabetes 
Presence of central obesity with waist 
circumference >86 cm (men) and >83 cm 
(women) plus any 2 of the following: 
(i) TG >150 mg/dl or specific treatment for 
this lipid abnormality 
(ii) HDL-C <40 mg/dl (men), <50 mg/dl 
(women) or specific treatment for this lipid 
abnormality 
(iii) SBP >130 mmHg and/or DBP >85 
mmHg or medical treatment for previously 
diagnosed hypertension 
(iv) Fasting plasma glucose (>100 mg/dl) or 
previously diagnosed type 2 diabetes 
ATPIII: Adult Treatment Panel III, IDF: International diabetes federation, NEW: New criteria for Kerman. 
 
Table 2: Neurophysiological Classification of CTS 




Absence of sensory response, abnormal distal motor latency 
Abnormal Distal sensory latency, abnormal distal motor latency 
Abnormal Distal sensory latency, normal distal motor latency 
Carpal Tunnel Syndrome in Diabetic Patients Journal of Endocrinology and Diabetes Mellitus, 2016, Vol. 4, No. 1      13 
Table 3: The Frequency of Study Variables in 439 Diabetic Patients 
 Those with signs of CTS Those without signs of CTS P-Value 
Age (years) 55.31 (9.27) 56.50 (10.24) 0.30 
Male (frequency) 41.00 (29.70) 154.00 (51.20) 0.001* 
Duration of diabetes (months) 64.84 (55.45) 68.00 (60.46) 0.72 
Weight (kg) 72.69 (14.02) 74.33 (13.72) 0.25 
BMI (kg/m2) 28.01 (5.46) 27.54 (4.57) 0.36 
Systolic Blood pressure (mmHg) 126.03 (20.94) 130.55 (20.26) 0.03* 
Diastolic Blood pressure (mmHg) 80.85 (10.50) 81.95 (10.04) 0.29 
Cardio-vascular disease 35.00 (25.43) 63.00 (20.90) 0.30 
Fasting Blood Sugar (mg/dl) 168.58 (73.75) 158.60 (62.20) 0.114 
Cholesterol (mg/dl) 209.21 (55.02) 201.83 (47.73) 0.155 
TG (mg/dl) 199.11 (136.37) 184.83 (117.75) 0.27 
HDL (mg/dl) 36.97 (11.02) 37.22 (17.29) 0.88 
LDL (mg/dl) 134.46 (42.74) 128.23 (37.73) 0.125 
ATPIII 97.00 (70.30) 216.00 (71.80) 0.75 
IDF 94.00 (68.10) 188.00 (62.50) 0.25 
NEW 103.00 (74.60) 222.00 (73.80) 0.84 
Qualitative variables are mentioned as frequency (percent) and Quantitative variables are reported as mean (standard deviation). 
 
Table 4: The Frequency of Study Variables in 105 Paients Reffered to Neurologist  
 Those affected by CTS Those without CTS  P-VALUE 
Age (years) 59.13(8.79) 52.29 (10.24) 0.004* 
Male (percent) 22 (27.20) 6 (25) 0.83 
Duration of diabetes (months) 94.41(72/79) 71.00(58.45) 0.156 
Previous history of wrist fraction 4(3.70) 0 0.999 
Dimensions of the right hand’s wrist (ratio) 0.68(0.05) 0.66(0.04) 0.039* 
Dimensions of the left hand’s wrist (ratio) 0.70 (0.11) 0.67(0.04) 0.067 
Weight (kg) 75.27 (14.73) 75.02(13.61) 0.94 
BMI (kg/m2) 29.17 (5.88) 29.14 (4.83) 0.98 
Systolic Blood pressure (mmHg) 131.01 (17.84) 122.71 (21.78) 0.063 
Diastolic Blood pressure (mmHg) 81.63 (10.11) 80.83 (11.74) 0.719 
Cardio-vascular disease  24 (29.60) 4 (16.70) 0.214 
Fasting Blood Sugar (mg/dl) 185.86(79.08) 151.71(54.53) 0.056 
Cholesterol (mg/dl) 209.38 (49.40) 206.25 (45.15) 0.78 
TG (mg/dl) 194.23(100.96) 189.21(91.94) 0.83 
HDL(mg/dl) 37.25 (9.46) 35.45 (7.60) 0.39 
LDL (mg/dl) 136.93(44.94) 135.26(39.96) 0.86 
ATPIII 68 (84) 19 (79.20) 0.69 
IDF 58 (71.60) 20 (83.30) 0.24 
NEW 61(75.30) 19(79.20) 0.58 
Qualitative variables are mentioned as frequency (percent) and Quantitative variables are reported as mean (standard deviation). 
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Table 5: The Prevalence of Carpal Tunnel Syndrome in People with and without Metabolic Syndrome Based on the 3 
Criteria with Sex Subgroups 
 in females P-value in males P-value Overall prevalence P-value 
ATPIII Criteria  
with MS 30.95 0.776 14.71 0.341 24.43 0.845 
without MS 29.30  19.27  23.70  
IDF Criteria 
with MS 30.84 0.883 15.07 0.636 25.70 0.251 
without MS 32.38  17.21  21.57  
New Criteria 
with MS 30.66 0.992 15.19 0.488 23.89 0.752 
without MS 30.61  18.61  25.05  
 
Table 6: The Prevalence of Carpal Tunnel Syndrome in Patients with and without Metabolic Syndrome Based on 
Combination of Two and all Criteria  
Criteria ATPIII*IDF ATPIII*NEW IDF*NEW ATPIII*IDF*NEW 
With metabolic syndrome 24.68 24.42 24.28 24.37 
Without metabolic syndrome  22.38 23.30 24.09 23.56 
 
from June 1998 to August 1999the prevalence of 
metabolic syndrome in diabetics without 
polyneuropathy was 14% [18]. In other studies, the 
prevalence of this syndrome was reported 20% in 
diabetic patients [19]. In the present study the 
prevalence of metabolic syndrome was higher than 
these studies. This fact might show the worse situation 
of diabetic patients in our study, not diagnosing the 
disease in early stages or faster disease progression in 
our population.  
The prevalence of carpal tunnel syndrome in the 
general population is about 2.7 percent [2, 20]. It has 
been mentioned in other references that the prevalence 
of carpal tunnel syndrome in diabetic patients is much 
higher than the general population and indicates that 
diabetic patients are at a higher risk for developing 
carpal tunnel syndrome. Other studies also confirm that 
diabetes is a risk factor for carpal tunnel syndrome [4, 
5, 21, 22]. 
In the present study, the prevalence of carpal tunnel 
syndrome in diabetic men was 16.21 percent and in 
diabetic women was 30.65 percent. The results 
showed that there is significant difference in the 
prevalence of carpal tunnel syndrome in men and 
women. According to studies conducted in the general 
population, the prevalence of carpal tunnel syndrome in 
women is much higher than men, and women are 3 to 
10 times more susceptible to acquiring carpal tunnel 
syndrome [1, 3, 6, 23]. This probably means that some 
sex-related risk factors might play a role in the 
pathogenesis of carpal tunnel syndrome. 
A study done in Kerman city, showed females were 
4 times more likely than males to acquire carpal tunnel 
syndrome [24]. 
Researchers have suggested that the higher 
incidence of carpal tunnel syndrome in females may 
have been caused by the specific anatomical structure 
of the wrist as well as the higher activity of the upper 
extremities in women [25]. 
Our results showed that there is no significant 
difference in the prevalence of carpal tunnel syndrome 
in people with and without metabolic syndrome. 
However even after extensive searching, we could not 
find any similar study to compare our results. However, 
studies on people with carpal tunnel syndrome done by 
Balci and Ander in Turkey show a higher frequency of 
metabolic syndrome among people with carpal tunnel 
syndrome [7, 26]. A large number of studies have 
shown that metabolic syndrome is a risk factor for 
carpal tunnel syndrome [6-8, 27-29]. But in the present 
Carpal Tunnel Syndrome in Diabetic Patients Journal of Endocrinology and Diabetes Mellitus, 2016, Vol. 4, No. 1      15 
study no significant difference was seen between the 
prevalence of carpal tunnel syndrome in diabetic 
patients with and without metabolic syndrome. 
However, we cannot conclude that metabolic syndrome 
is not a risk factor for carpal tunnel syndrome, because 
the other studies about carpal tunnel syndrome and 
metabolic syndrome have been conducted in the 
general population, but the present study was 
conducted among a population of patients with type 2 
diabetes whom a high percentage (nearly 70%) already 
had metabolic syndrome [30]. Therefore it is necessary 
to conduct more studies on nondiabetics, to be able to 
find more conclusive results. 
The present study found that there is no significant 
difference in carpal tunnel syndrome severity in 
diabetic patients with and without metabolic syndrome. 
However, there is no perfect gold standard for carpal 
tunnel syndrome diagnosis. Some believe that the 
combination of electro diagnostic study findings and 
symptom characteristics will provide the most accurate 
information for classification of carpal tunnel syndrome 
[31]. In this study we also used a combination of clinical 
findings and electro diagnostic data to diagnose carpal 
tunnel syndrome.  
There is limited information about the severity of the 
disease in people with and without metabolic syndrome 
in the general population; however few studies have 
shown more severity in people with metabolic 
syndrome [7, 26]. The fact that we did not observe 
significant differences in the severity of disease in the 
present study can be due to investigating this 
syndrome in diabetic patients, whereas, other studies 
have investigated the severity of the disease in non-
diabetic people. 
CONCLUSION 
The present study shows that the prevalence of 
Carpal tunnel syndrome in people with type 2 diabetes 
is very high in Kerman. But there is no significant 
difference in the prevalence of carpal tunnel syndrome 
in diabetic patients with and without metabolic 
syndrome. Therefore more studies are needed in this 
field. 
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